Freeman Kevin D

EDGAR CIK 0001522478

Galectin Therapeutics Inc - GALT

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director
Direct Buys
4
$39,561
21,300 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$13,500
5,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/17/2025
07/18/2025
Buy
5,000 @ $2.90
 $14,495 49,769 (11.17%) Direct
12/24/2024
12/26/2024
Buy
10,000 @ $0.81
 $8,134 44,769 (28.76%) Direct
10/17/2024
10/17/2024
Buy
1,300 @ $2.64
 $3,432 34,769 (3.88%) Direct
10/16/2024
10/16/2024
Buy
5,000 @ $2.70
 $13,500 33,469 (17.56%) Direct
10/16/2024
10/16/2024
Buy
5,000 @ $2.70
 $13,500 80,000 (6.67%) Indirect - By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC